海马区保护治疗小细胞肺癌全脑照射的研究进展

doi:10.11904/j.issn.1002-3070.2019.04.018

Abstract

Abstract: About 15% to 20% of patients with small cell lung cancer(SCLC)have brain metastases at the time of initial diagnosis,and more than 80% of patients eventually develop brain metastases.Whole brain radiotherapy(WBRT)is the standard treatment for brain metastases in lung cancer.Whole brain prophylactic irradiation(PCI)is an effective treatment for preventing brain metastases in SCLC.With the improvement of treatment technology and the standard of treatment,the survival of SCLC patients is prolonged.The use of spiral tomography(TOMO)technology for hippocampal-protected WBRT in PCI or brain metastasis can reduce neurocognitive impairment and improve the life quality of patient.

Key words: Small cell lung cancer, Whole brain radiotherapy, Prophylactic carnial irradiation, Hippocampal protection

CLC Number:

R734.2

ZHU Shijia, XU Xiangying. Advance of whole brain radiotherapy irradiation of hippocampus in the treatment of small cell lung cancer[J]. Journal of Practical Oncology, 2019, 33(4): 380-383.

References

1 Auperin A,Arriagada R,Pignon JP,et al.Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.Prophylactic Cranial Irradiation Overview Collaborative Group[J].N Engl J Med,1999,341(7):476-84.
2 Slotman B,Faivre FC,Kramer G,et al.Prophylactic cranial irradiation in extensive small-cell lung cancer[J].N Engl J Med,2008,357(7):664-672.
3 Gondi V,Hermann BP,Mehta MP,et al.Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors[J].Int J Radiat Oncol Biol Phys,2012,83(4):487-493.
4 Redmond KJ,Mahone EM,Terezakis S,et al.Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children:a prospective study[J].Neuro Oncol,2013,15(3):360-369.
5 Gondi V,Tome WA,Mehta MP.Why avoid the hippocampus? a comprehensivereview[J].Radiother Oncol,2010,97(3):370-376.
6 Shaw MG,Ball DL,Bhb MB,et al.Treatment of brain metastases in lung cancer:strategies to avoid/reduce late complications of whole brain radiation therapy[J].Curr Treat Options Oncol,2013,14(4):553-567.
7 Brown PD,Jaeckle K,Ballman KV,et al.Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases:arandomized clinical trial[J].JAMA,2016,316(4):401-409.
8 Goings GE,Sahni V,Szele FG,et al.Migration patterns of subventricular zone cells in adult mice change after cerebral cortex injury[J].Brain Res,2004,996(2):213-226.
9 Sato Y,Shinjyo N,Sato M,et al.Grafting neural stemand progenitor cells into the hippocampus of juvenile,irradiated mice normalizes behavior deficits[J].Front Neurol,2018,9:715.
10 Kristin JR,Hales MD,Heather A,et al.Prospective study of hippocampal-sparing prophylactic cranial irradiation in limited-stage small cell lung cancer[J].Int J Radiat Oncol Biol Phys,2017,98(3):603-611.
11 Lin SY,Yang CC,Wu YM,et al.Evaluating the impact of hippocampal-sparing during whole-brain radiotherapy on neurocognitive functions:a preliminary report of a prospective phase II study[J].Biomed J,2015,38(5):439-449.
12 Gondi V,Pugh SL,Tome WA,et al.Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases(RTOG 0933):a phase II multi-institutional trial[J].J Clin Oncol,2014,32(4):3810-3816.
13 Harth S,Abo-madyan Y,Zheng L,et al.Estimation of intracranial failure risk following hippocampal-sparing whole-brain radiotherapy[J].Radiother Oncol,2013,109(1):152-158.
14 Gondi V,Tome WA,Marsh J,et al.Estimated risk of perihippocampal disease progression after hippocampal avoidance during whole-brain radiotherapy:safety profile for RTOG 0933[J].Radiother Oncol,2010,95(3):327-331.
15 Marsh JC,Herskovic AM,Gielda BT,et al.Intracranial metastatic disease spares the limbic circuit:a review of 697 metastatic lesions in 107 patients[J].Int J Radiat Oncol Biol Phys,2010,76(2):504-512.
16 Wan JF,Zhang SJ,Wang L,et al.Implications for preserving neural stem cells in whole-brain radiotherapy and prophylactic cranial irradiation:a review of 2270 metastases in 488 patients[J].J Radiat Res,2013,54(2):285-291.
17 Ghia A,Tome WA,Thomas S,et al.Distribution of brain metastases in relation to the hippocampus:implications for neurocognitive functional preservation[J].Int J Radiat Oncol Biol Phys,2007,68(4):971-977.
18 Oskan F,Ganswindt U,Schwarz SB,et al.Hippocampus-sparing in whole-brain radiotherapy.a review[J].Strahlenther Onkol,2014,190(4):337-341.
19 Prokic V,Wiedenmann N,Fels F,et al.Whole brain irradiation with hippocampal-sparing and dose escalation on multiple brain metastases:a planning study on treatment concepts[J].Int J Radiat Oncol Biol Phys,2013,85(1):264-270.
20 Gondi V,Hermann BP,Mehta MP,et al.Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors[J].Int J Radiat Oncol Biol Phys,2012,83(4):487-493.
21 Tsai PF,Yang CC,Chuang CC,et al.Hippocampal dosimetry correlates with the change in neurocognitive function after hippocampal sparing during whole brain radiotherapy:a prospective study[J].Radiat Oncol,2015,10(1):253.
22 Gondi V,Tolakanahalli R,Mehta MP,et al.Hippocampal-sparing whole-brain radiotherapy:a “how-to” technique using helical tomotherapy and linear accelerator-based intensity-modulated radiotherapy[J].Int J Radiat Oncol Biol Phys,2010,78(4):1244-1252.
23 Rong Y,Josh E,Meng XW,et al.Dosimetric evaluation of intensity-modulated radiotherapy,volumetric modulated arc therapy,and helical tomotherapy for hippocampal-avoidance whole brain radiotherapy[J].PLoS One,2015,10(4):e0126222.
24 Marsh JC,Gielda BT,Herskovic AM,et al.Sparing of hippocampus and limbic circuit during whole brain radiation therapy:a dosimetric study using helicaltomotherapy[J].J Med Imaging Radiat Oncol,2010,54(4):375-382.

[1]	LI Wanzhen, YIN Jun, LI Ping, LIN Xiaohui, ZHANG Guoqian, ZHANG Shuxu. The expression and role of miR-17 in radioresistant cells of non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 391-397.
[2]	CAI Jing, HOU Yue. The expression and clinical significance of serum miR-195 in patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 415-419.
[3]	CUI Xiaoyan,TU Qing,GAN Jianhui. Comparison between nalbuphine and oxycodone applied for patient controlled analgesia on postoperative immunological factor levels in patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 309-314.
[4]	LEI Junhua, XU Guanhua, ZENG Jiangzheng, HUANG Fen, HE Zhihui, LU Yanda. Research on JAK3/STAT3 mechanism of non-small cell lung cancer NCI-H1975 cells treated with cryptotanshinone combined with cisplatin [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 198-202.
[5]	ZHAI Keke, GAO Yuanyuan, FENG Xiao, XU Jingwen, GONG Yufang, MENG Qingwei. Analysis of first-line NSCLC chemotherapy in the phase Ⅳ patients with distant metastasis and first diagnosis after postoperative adjuvant chemotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 107-111.
[6]	DU Yesheng, HU Songliu, XU Xiangying. Study of oligodendrocyte metastasis in non-small cell lung cancer by stereotactic radiotherapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(2): 154-158.
[7]	YANG Wenjuan, YU Jing, HUANG Zhao, ZHANG Junhong, XIE Conghua. Correlation between the decline of severe granulocyte in the early stage of chemotherapy and the prognosis of small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 19-24.
[8]	SUN Mingliang, XU Jianyu, XU Xiangying. Stereotactic radiotherapy for early stage of non - small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 53-56.
[9]	DAI Xin, ZHANG Daxin. Current status of anti-angiogenesis therapy for non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(5): 472-476.
[10]	HU Haifeng,FENG Xiemin,QIAO Jian,DUAN Wei,LIU Ningning,SUN Xiaodong. The expression and clinical significance of miR-345 in non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(2): 117-122.
[11]	ZHANG Rui,WANG Zhiyu,WANG Shuai,ZHAO Hui. Efficacy of recombinant human endostatin combined with vinorelbine-cisplatin regimen in newly diagnosed patients with advanced non-small cell lung cancer patients with bone metastases and the impact on expression of serum VEGF [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(6): 527-522.
[12]	XIAO Yao, XU Xiangying, HU Songliu. Treatment of small cell lung cancer in elderly patients [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(5): 463-467.
[13]	REN Fenghai,WANG Dandan,WANG Junfeng,XU Hai,XU Shidong. Clinical comparative study between Uniportal and single port video-assisted thoracoscopic surgery for ⅠA stage non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(4): 327-331.
[14]	YE Leiguang, YAN An, LIU Baogang. Relationship between Aurora-A mediated drug resistance and prognosis of patients with non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(2): 97-102.
[15]	CHEN Minghui, CHEN Xijie, WANG Yan. Research progress of CD44v6 in non-small cell lung cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2016, 30(2): 172-175.

Advance of whole brain radiotherapy irradiation of hippocampus in the treatment of small cell lung cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments